CHOSA Oncology AB

Chosa Oncology is a Swedish-Danish biotechnology company that develops solutions for personalized cancer treatment with a focus on diagnostics and drug formulation. The company targets healthcare providers and research actors and works internationally with partners and clinical projects. Chosa Oncology was founded in 2022 and is headquartered in Lund, Sweden.

Quotes for CHOSA Oncology AB

Board

CEO

  • Peter Buhl

Chairperson of the Board

  • Ingrid Atteryd Heiman

Board

  • Claus Frisenberg Pedersen
  • Fred Hirsch
  • Morten Myrhøj
  • Ulla Hald Buhl
Articles of association
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months Q1 3 Months 2024
Total revenue MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings before interest and tax MSEK -1.96 -6.23 -0.12 -2.49 2.51 -1.53 -9.71
Profit before tax MSEK -1.87 -6.62 -0.70 -2.54 2.65 -1.81 -9.59
Net profit MSEK -1.87 -5.61 -0.70 -2.54 2.65 -1.81 -9.59
Earnings per share SEK -0.02 -0.07 -0.05 -0.03 0.04 -0.03 -0.14
Dividend per share SEK 0,00 0.00 0.00 0,00 0,00 0,00 0.00
Equity MSEK 21.67 16.54 16.54 16.13 14.47 11.63 13.82
Fixed assets MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Intangible assets MSEK 16.80 16.62 16.62 13.06 13.17 9.02 9.56
Current assets MSEK 7.01 3.63 3.63 4.03 3.27 3.95 7.03
Total asset MSEK 23.81 20.25 20.25 17.09 16.44 12.98 16.59
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 2.14 3.71 3.71 0.96 1.97 1.35 2.77
Number of shares SEK 87863672.00 78895886.00 78895886.00 78895886.00 70944146.00 70944146.00 70944146.00
*Compiled data from Millistream